Longevity Medicine, Functional Wellness & Anti-Aging Insights from HormoneSynergy®

Homocysteine is an often-overlooked marker that may reflect methylation status, vascular stress, and elevated risk to long-term brain health. In longevity medicine, it can provide deeper context beyond standard labs alone.

Compounding pharmacies in the United States are regulated—but not the same as FDA-approved drug manufacturers. This article explains the real differences, what’s legal, what’s not, and how to separate fact from misinformation around peptides and compounded therapies.

F2-isoprostane is a marker of lipid peroxidation and oxidative stress. In longevity medicine, it may help reveal whether the body is experiencing excess oxidative damage linked to metabolic dysfunction, inflammation, and unhealthy aging.

IL-6 is a signaling molecule involved in immune activity and inflammation. When elevated over time, it may reflect chronic inflammatory stress linked to cardiometabolic disease, frailty, and unhealthy aging.

hs-CRP is a simple blood marker that can reveal low-grade inflammation linked to cardiovascular risk, metabolic dysfunction, and unhealthy aging. In longevity medicine, it helps identify hidden inflammatory burden before disease becomes obvious.

Inflammation is part of the body’s normal defense system, but when it becomes chronic or dysregulated, it may affect brain function, mood, cognitive clarity, and long-term health. Understanding this connection is an important part of longevity medicine.

The term “Type 3 Diabetes” has been used to describe patterns of insulin resistance in the brain. While not an official diagnosis, it reflects a growing understanding of how metabolic health may influence cognitive function over time.

Insulin resistance is a foundational driver of metabolic dysfunction that may also influence brain health over time. Understanding this connection is key to protecting long-term cognitive function and overall longevity.

Fasting insulin is one of the earliest indicators of metabolic dysfunction—and it may also play a role in long-term brain health. Even when glucose appears normal, elevated insulin can signal underlying risk.

Lp(a) is a genetic cardiovascular risk marker often missed in routine labs. Learn why elevated lipoprotein(a) matters for longevity and preventive cardiology.

The idea that Alzheimer’s is “Type 3 diabetes” has gained traction—but it’s not the full story. Here’s what’s true, what’s oversimplified, and how this fits into a longevity medicine perspective.

A recent large observational study suggests statins may be associated with lower Alzheimer’s risk, but the full story is more complex. Here’s what the data actually shows, what it does not prove, and how it fits into a longevity medicine perspective.